Medical Affairs: Delivering Strategic Value

Table of Contents

Metrics Overview

Medical Affairs contains the following metrics:

• Medical Affairs Reporting Structures 2002 vs. 2008
• Companies' Medical Affairs Structures
• Medical Affairs Internal Alignment
• Medical Affairs Reporting Structure in 2002
• Medical Affairs Reporting Structure in 2008
• Company I' s US Medical Affairs Structure
• Company K' s Scientific Affairs Structure
• Medical Affairs Funding Source(s)
• Company Medical Affairs Funding Source(s)
• 2008 US Medical Affairs Budgets
• 2008 US Medical Affairs Budget Allocation
• Company Medical Affairs Budget Allocations by Function
• Average US Medical Affairs Budget by Activity
• 2008 Medical Affairs Budget Allocation ($10 Million or Less)
• 2008 Medical Affairs Budget Allocation (More Than $10 Million)
• 2008 US Thought Leader Spending
• 2008 US MSL Programs Spending
• 2008 US Medical Publications Spending
• 2008 US Medical Education Spending
• 2008 US Medical Information Spending
• 2008 US Investigator-Initiated Trials Spending
• 2008 US Medical Grants Spending
• 2008 US Other Spending
• 2008 US Medical Affairs Budgets and Staffing Resource Allocation
• 2008 Medical Affairs Staffing
• 2008 US Medical Affairs Staffing Allocation
• Company Medical Affairs Staffing Allocations by Function
• Average US Medical Affairs Staffing by Activity
• 2008 US Medical Affairs Staffing Allocation
• 2008 US Thought Leader Headcounts
• 2008 US MSL Program Headcounts
• 2008 US Medical Publications Headcounts
• 2008 US Medical Education Headcounts
• 2008 US Medical Information Headcounts
• 2008 US Investigator-Initiated Trials Headcounts
• 2008 US Medical Grants Headcounts
• 2008 US Other Headcounts
• Percentage of Average US Medical Affairs Budget Outsourced in 2008
• Percentage of 2008 US Medical Affairs Budget Outsourced by Company
• Outsourced US Medical Affairs Budget in 2008
• Weighing Outsourcing Advantages vs. Disadvantages
• Medical Affairs Strategy, Activities and Compliance
• Aligning Medical Affairs with Brand Strategy
• Thought Leaders: First Involvement During Drug Development
• Thought Leaders: Last Involvement With a Drug
• MSL Programs: First Involvement During Drug Development
• MSL Programs: Last Involvement With a Drug
• Medical Publications: First Involvement During Drug Development
• Medical Publications: Last Involvement With a Drug
• Medical Education: First Involvement During Drug Development
• Medical Education: Last Involvement With a Drug
• Medical Information: First Involvement During Drug Development
• Medical Information: Last Involvement With a Drug
• Investigator-Initiated Trials: First Involvement During Drug Development
• Investigator-Initiated Trials: Last Involvement With a Drug
• Medical Grants: First Involvement During Drug Development
• Medical Grants: Last Involvement With a Drug
• Medical Affairs Compliance
• Impact of OIG Guidelines
• Impact of Uniform Requirements from International Committee of Medical Journal Editors (ICMJE)
• Impact of Good Publication Practices (GPP)
• Impact of CONSORT Statement
• Impact of Food and Drug Administration Modernization Act (FDAMA)
• Impact of PhRMA code
• Impact of GCP Code